Targeting the cancer initiating cell: the Achilles' heel of cancer.

[1]  J. McCubrey,et al.  The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. , 2010, Biochimica et biophysica acta.

[2]  J. McCubrey,et al.  The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology , 2010, Cancers.

[3]  E. Ho,et al.  Anti-inflammatory activity of soy and tea in prostate cancer prevention , 2010, Experimental biology and medicine.

[4]  S. Leinster,et al.  Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials , 2010, Human reproduction update.

[5]  Stephen L. Abrams,et al.  Emerging MEK inhibitors , 2010, Expert opinion on emerging drugs.

[6]  M. Messina.  Soybean isoflavone exposure does not have feminizing effects on men: a critical examination of the clinical evidence. , 2010, Fertility and sterility.

[7]  M. Mimeault,et al.  Cytotoxic Effects Induced by Docetaxel, Gefitinib, and Cyclopamine on Side Population and Nonside Population Cell Fractions from Human Invasive Prostate Cancer Cells , 2010, Molecular Cancer Therapeutics.

[8]  Stephen L. Abrams,et al.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells. , 2010, Advances in enzyme regulation.

[9]  P. Chang,et al.  Formation of succinyl genistin and succinyl daidzin by Bacillus species. , 2010, Journal of food science.

[10]  Stephen L. Abrams,et al.  Emerging Raf inhibitors , 2009, Expert opinion on emerging drugs.

[11]  J. McCubrey,et al.  Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs , 2009, The Prostate.

[12]  Andrew J Vickers,et al.  Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. McCubrey,et al.  Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia , 2009, Expert opinion on investigational drugs.

[14]  J. Lampe.  Is equol the key to the efficacy of soy foods? , 2009, The American journal of clinical nutrition.

[15]  Massimo Libra,et al.  PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches , 2009, Cell cycle.

[16]  Shaw Watanabe,et al.  Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. , 2009, The Journal of nutrition.

[17]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[18]  J. Shay,et al.  Prostate tumor-initiating cells: a new target for telomerase inhibition therapy? , 2009, Biochimica et biophysica acta.

[19]  Sendurai A Mani,et al.  The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies , 2009, Journal of Mammary Gland Biology and Neoplasia.

[20]  A. Hodge,et al.  Can the Mediterranean diet prevent prostate cancer? , 2009, Molecular nutrition & food research.

[21]  Zhiwei Wang,et al.  Multi-targeted therapy of cancer by genistein. , 2008, Cancer letters.

[22]  J. McCubrey,et al.  Akt as a therapeutic target in cancer , 2008 .

[23]  H. Christiansen,et al.  In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol , 2008, Radiation oncology.

[24]  Stephen L. Abrams,et al.  Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors , 2008, Oncogene.

[25]  Misop Han,et al.  Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. , 2008, JAMA.

[26]  Massimo Libra,et al.  Targeting prostate cancer based on signal transduction and cell cycle pathways , 2008, Cell cycle.

[27]  N. Maitland,et al.  Prostate cancer stem cells: a new target for therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[29]  A. Maitra,et al.  Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer. , 2008, Bioorganic & medicinal chemistry.

[30]  C. Takimoto,et al.  Dietary genistein inhibits metastasis of human prostate cancer in mice. , 2008, Cancer research.

[31]  J Cuzick,et al.  Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer , 2008, Oncogene.

[32]  Stephen L. Abrams,et al.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. , 2007, Biochimica et biophysica acta.

[33]  D. Terrian,et al.  Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway , 2007, Cancer biology & therapy.

[34]  R. Godschalk,et al.  Dietary flavonoids induce MLL translocations in primary human CD34+ cells. , 2007, Carcinogenesis.

[35]  O. Witte,et al.  Stem cells in prostate cancer initiation and progression. , 2007, The Journal of clinical investigation.

[36]  Jun-shik Choi,et al.  Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. , 2007, International journal of pharmaceutics.

[37]  Sanjeev Banerjee,et al.  Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model , 2007, International journal of cancer.

[38]  D. Terrian,et al.  A Dominant Role for p53-Dependent Cellular Senescence in Radiosensitization of Human Prostate Cancer Cells , 2007, Cell cycle.

[39]  H. Zhang,et al.  Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. , 2007, Cancer research.

[40]  Jingfeng Li,et al.  Parthenolide Inhibits IκB Kinase, NF-κB Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice , 2007 .

[41]  J. McCubrey,et al.  Activation of the calcium/calmodulin-dependent protein kinases as a consequence of oxidative stress. , 2006, Antioxidants & redox signaling.

[42]  J. McCubrey,et al.  Molecular pathways leading to oxidative stress-induced phosphorylation of Akt. , 2006, Antioxidants & redox signaling.

[43]  P. Scardino,et al.  Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. , 2006, The Journal of urology.

[44]  F. Sarkar,et al.  Prostate Cancer Treatment is Enhanced by Genistein In Vitro and In Vivo in a Syngeneic Orthotopic Tumor Model , 2006, Radiation research.

[45]  Yiwei Li,et al.  Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. , 2006, Cancer research.

[46]  F. Sarkar,et al.  Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest , 2006, BMC Cancer.

[47]  Georg Bartsch,et al.  Cancer of the prostate. , 2005, Critical reviews in oncology/hematology.

[48]  E. Giovannucci,et al.  Role of diet in prostate cancer development and progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  Stephen L. Abrams,et al.  The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what’s genetics got to do with it? , 2005, Expert opinion on therapeutic targets.

[50]  J. McCubrey,et al.  Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy , 2005, Expert opinion on therapeutic targets.

[51]  M. Ronis,et al.  Soy Protein Isolate and Protection Against Cancer , 2005, Journal of the American College of Nutrition.

[52]  J. Moul,et al.  Rising prostate-specific antigen after primary prostate cancer therapy , 2005, Nature Clinical Practice Urology.

[53]  F. E. Bertrand,et al.  The complexity of PTEN: mutation, marker and potential target for therapeutic intervention , 2004, Expert opinion on therapeutic targets.

[54]  J. McCubrey,et al.  Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells , 2004, Oncogene.

[55]  Frank McCormick,et al.  Activation of the hedgehog pathway in advanced prostate cancer , 2004, Molecular Cancer.

[56]  F. Sarkar,et al.  Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. , 2004, Molecular cancer therapeutics.

[57]  M. Ravindranath,et al.  Anticancer therapeutic potential of soy isoflavone, genistein. , 2004, Advances in experimental medicine and biology.

[58]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Inoue,et al.  Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by Dehydroxymethylepoxyquinomicin* , 2002, The Journal of Biological Chemistry.

[60]  Y. Ju,et al.  Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. , 2002, Cancer research.

[61]  M. D. Lemos.  Effects of Soy Phytoestrogens Genistein and Daidzein on Breast Cancer Growth , 2001 .

[62]  A. Partin,et al.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.

[63]  Y. Ju,et al.  Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. , 2001, Cancer research.

[64]  F. Sarkar,et al.  Genistein potentiates the radiation effect on prostate carcinoma cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[65]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[66]  S. Haslam,et al.  Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. , 1998, Cancer research.

[67]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[68]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.